US Patent 11851445 Compounds and uses thereof

Is a

Patent

Patent attributes

Patent Applicant

Foghorn Therapeutics

Current Assignee

Foghorn Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

118514450

Patent Inventor Names

Sabine K. Ruppel0

Jason T. Lowe0

Johannes H. Voigt0

Zhaoxia Yang0

Date of Patent

December 26, 2023

Patent Application Number

171626080

Date Filed

January 29, 2021

Patent Citations

‌

US Patent 6905681 Methods for selectively stimulating proliferation of T cells

‌

US Patent 6867041 Simultaneous stimulation and concentration of cells

‌

US Patent 6887466 Methods for selectively stimulating proliferation of T cells

‌

US Patent 6905680 Methods of treating HIV infected subjects

‌

US Patent 7232566 Methods for treating HIV infected subjects

‌

US Patent 9271978 Heterocyclic compounds as bromodomain inhibitors

‌

US Patent 9353051 Antiviral drugs for treatment or prevention of dengue infection

‌

US Patent 9410943 Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma

...

Patent Primary Examiner

CPC Code

Patent abstract

The present disclosure features compounds useful for the treatment of BAF complex-related disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11851445 Compounds and uses thereof

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11851445 Compounds and uses thereof